Menetelmä mikropartikkelien valmistamiseksi

摘要

A sustained release formulation of a peptide drug compound, preferably a somatostatin like octreotide, e.g. as a pamoate salt. The drug compound is present in a polymeric carrier, preferably a polylactide-co-glycolide especially a poly(lactide-co-glycolide)glucose. The formulation is preferably a depot formulation in the form of a monolithic microparticle.